Lashanda Tate

Recommended Articles

• New App is Helping Lupus Patients Fulfill Gaps in Treatment

  It is not a secret that lupus can be one of the most annoying and challenging conditions someone could suffer from. Not only is it a disease that requires constant evaluation for a long period of time in order to be diagnosed, but it is also characterized by its flare, which can even require staying...

• Holistic Treatment to Head Lice

  Head lice, also known as nits, are minute, tiny, wingless insects that feed on human blood. They are not deadly. However, the can negatively affect your child’s life. Therefore, head lice should not be left untreated. Several holistic treatment options are existent. They...

• How to Help a Loved One with Rheumatoid Arthritis

  There are many times in which having a chronic disease can feel very lonely. Others around them may have a difficult time understanding their pain, especially if they look healthy or do not complain much about their ailment. Children may not be old enough to comprehend the challenges their parent...

• How REM Sleep Behavior Disorder Ties in with Parkinson's Disease

  Some may have heard about the unbelievable stories of sleepwalkers driving cars in the middle of the night or walking for miles without ever being conscious of it. Maybe, these stories sound a little out there, however the symptoms and side-effects of sleep disorders vary largely from person to...

• Is Your Child at Risk of Osgood-Schlatter Disease?

  Our body is a machine and any wear and tear occurring in any of the parts of the body can impair overall body functioning. One of the common types of pain felt by a number of people is pain associated with the knees. There are various forms and causes that could be related to knee pains, one of them...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...